Showing 1051-1060 of 18563 results for "".
Improving Sleep and Mental Health in Patients with CKD-aP
https://reachmd.com/programs/cme/improving-sleep-and-mental-health-in-patients-with-ckd-ap/36301/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Diagnosing IBS-C: From Clinical Clues to Confident Calls
https://reachmd.com/programs/clinicians-roundtable/diagnosing-ibs-c-from-clinical-clues-to-confident-calls/29891/Among patients with irritable bowel syndrome with constipation (IBS-C), only 24 percent have a diagnosis, while 62 percent remain undiagnosed and seeking care.1 And when IBS goes undiagnosed, patients can experience prolonged pain, suffering, and anxiety due to the disease and its associated comorbiClearing the Brain Fog: Innovations in the Treatment and Management of Hepatic Encephalopathy
https://reachmd.com/programs/cme/Clearing-the-Brain-Fog-Innovations-in-the-Treatment-and-Management-of-Hepatic-Encephalopathy/39047/Explore diagnostic and treatment challenges in patients with hepatic encephalopathy to improve outcomes for your patients.Kappa-Opioid Settings: Real-World Evidence Insights
https://reachmd.com/programs/cme/kappa-opioid-settings-real-world-evidence-insights/36300/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Introduction to Alloimmunization During Pregnancy
https://reachmd.com/programs/alloimmune-disorders-pregnancy/introduction-to-alloimmunization-during-pregnancy/13913/Can you successfully identify and treat your patients who may be at risk of alloimmune disorders of pregnancy?Achieving Success in IgAN & FSGS
https://reachmd.com/programs/cme/achieving-success-in-igan-fsgs/14677/Review underlying mechanisms of glomerulonephritis and sclerosis in patients with IgAN and FSGS and find out how emerging data may improve outcomes.Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
https://reachmd.com/programs/cme/current-and-emerging-roles-of-immunotherapy-and-adcs-for-patients-with-non-muscle-invasive-and-muscle-invasive-bladder-cancer/14553/Are you applying the latest data to your practice? Tune in for expert guidance on using ADCs and immunotherapy to treat your patients with mUC.The Clinical Significance of Imaging in the Management of ADPKD
https://reachmd.com/programs/cme/clinical-significance-imaging-management-adpkd/12675/When managing patients with autosomal dominant polycystic kidney disease, what role does radiological imaging play?Options for an Infant with Atopic Dermatitis
https://reachmd.com/programs/cme/options-for-an-infant-with-ad/11242/A mutlidisciplinary panel discusses treatment options for an infant with severe, refractory atopic dermatitis.Immunotherapy: Changing Patient Outcomes in SCLC
https://reachmd.com/programs/cme/immunotherapy-changing-patient-outcomes-in-sclc/10710/This activity offers expert insight into the practice-changing evidence on immunotherapy for the management of extensive-stage small cell lung cancer.